AL
VCYT icon

Airain Ltd’s Veracyte VCYT Stock Holding History

Airain Ltd’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,718
Closed -$98K – 1058
2017
Q1 		$98K Buy
+10,718
New +$87.7K ﹤0.01% 756

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Airain Ltd's VCYT Position: Q2 2017 in Review

Airain Ltd sold out of Veracyte (VCYT) in Q2 2017, closing a stake of 10,718 shares — an estimated $98K sold.

Airain Ltd first reported a position in VCYT in Q1 2017 and held it in 1 quarter. The position peaked at $98K in Q1 2017. 88 funds tracked by Wall St. Rank hold VCYT as of Q2 2017.

  • Airain Ltd reported no remaining Veracyte position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 10,718 Veracyte shares in Q2 2017, an estimated $98K.
  • Airain Ltd first reported a position in Veracyte in Q1 2017 and held it in 1 quarter.
  • Airain Ltd's Veracyte position peaked at $98K in Q1 2017.
  • 88 funds tracked by Wall St. Rank held Veracyte as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.